Skip to search.
 TSX Down 0.01% TSX Ventures Up 1.05%

More On DPH.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Dechra Pharmaceuticals plc (DPH.L)

-LSE
1,135.00 Down 2.00(0.18%) 7:42AM EDT
Prev Close:1,137.00
Open:1,128.00
Bid:1,132.00 x 8300
Ask:1,137.00 x 16400
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1,108.80 - 1,141.00
52wk Range:902.50 - 1,250.00
Volume:4,056
Avg Vol (3m):177,845
Market Cap:1.05B
P/E (ttm):49.35
EPS (ttm):23.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Headlines

Key Statistics

Forward P/E (1 yr):0.23
P/S (ttm):469.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :42.66
Quarterly EPS Est (Jun-16) :N/A
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dechra Pharmaceuticals plc develops, manufactures, sells, and markets veterinary pharmaceuticals and related products for veterinarians worldwide. It offers various dermatology and care, ophthalmology, anesthesia and analgesia, endocrinology, card... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback